Skip to main content
. 2019 May 30;8(11):e010814. doi: 10.1161/JAHA.118.010814

Table 6.

Clinical Characteristics by 1‐Month Fatality

Variables No Fatality (n=926) Fatality (n=94) Unadjusted Risk Estimates Adjusted Risk Estimates
% % RR 95% CI P Value RR 95% CI P Value
Age, mean, y 59.0 (14.2) 64.2 (14.3) 1.02 1.01–1.04 0.005a
Age >60 y 49.3 63.6 1.71 1.06–2.76 0.029a 1.84 1.06–3.18 0.029a
Sex
Male 58.6 54.6
Female 41.4 45.4 1.16 0.73–1.84 0.530 ··· ··· ···
Education
No formal education 13.9 15.2 1.00 ··· ··· ··· ··· ···
Primary 18.6 22.7 1.11 0.52–2.37 0.785 ··· ··· ···
Secondary 27.9 30.3 1.00 0.49–2.05 1.000 ··· ··· ···
Higher 39.6 31.8 0.76 0.37–1.55 0.449 ··· ··· ···
Hypertension 75 80.3 1.32 0.74 to 2.36 0.348 ··· ··· ···
Diabetes mellitus 12.6 10.6 0.83 0.39–1.77 0.637 ··· ··· ···
Dyslipidemia 63.8 68.2 1.20 0.73–1.96 0.480 ··· ··· ···
BMI 26.6 (5.3) 27.8 (4.9) 1.03 0.98–1.09 0.194 ··· ··· ···
Echo parameters, mean (SD)
Left atrial diameter 3.03 (2.33) 3.21 (0.96) 1.02 0.95–1.09 0.600 ··· ··· ···
Aortic root diameter 3.03 (0.69) 3.04 (0.55) 1.02 0.75–1.39 0.894 ··· ··· ···
Aortic valvular opening 1.97 (0.88) 1.88 (0.39) 0.76 0.39–1.45 0.402 ··· ··· ···
LVID 4.42 (0.96) 4.21 (1.20) 0.81 0.64–1.03 0.088 0.88 0.67–1.14 0.336
LVIDs 3.14 (1.59) 4.22 (9.13) 1.04 1.03–1.04 <0.001 1.01 0.99–1.03 0.394
IVSTD 1.44 (0.86) 1.55 (0.86) 1.09 0.89–1.35 0.384 ··· ··· ···
IVSTS 1.67 (0.55) 1.69 (0.71) 1.09 0.72–1.65 0.687 ··· ··· ···
LVPWTD 1.46 (0.81) 1.48 (0.59) 1.03 0.77–1.36 0.850 ··· ··· ···
LVPWTS 1.98 (1.30) 2.13 (1.34) 1.06 0.92–1.23 0.412 ··· ··· ···
EF, % 61.5 (15.3) 57.9 (15.6) 0.99 0.97–1.00 0.060 0.98 0.94–1.01 0.228
EF <50% 17.5 25.8 1.56 0.92–2.67 0.102
FS, % 34.0 (11.4) 31.9 (12.1) 0.98 0.96–1.01 0.154 ··· ··· ···
LVM indexed by height 62.7 (28.8) 55.9 (24.7) 1.00 0.97–1.01 0.520 ··· ··· ···
Abnormal LVM 63.8 58.3 0.81 0.37–1.76 0.594 ··· ··· ···
LV geometry
Normal 12.3 6.7 1.00 ··· ··· ··· ··· ···
Concentric remodeling 24.4 26.7 1.92 0.56–6.52 0.298 ··· ··· ···
Concentric hypertrophy 8 8.9 1.95 0.46–8.22 0.364 ··· ··· ···
Eccentric hypertrophy 55.3 57.8 1.84 0.58–5.88 0.302 ··· ··· ···
LV systolic dysfunction
None 72.2 93 1.00 ··· ··· 1.00 ··· ···
Mild 19.3 20.4 0.77 0.37–1.60 0.488 0.56 0.20–1.38 0.191
Moderate 5.6 7.4 1.38 0.68–2.82 0.372 0.71 0.20–2.49 0.589
Severe 2.8 9.3 3.05 1.36–6.83 0.007a 0.96 0.16–5.75 0.968
Left atrial enlargement 19.9 14.3 0.69 0.35–1.36 0.288 ··· ··· ···

EF indicates ejection fraction; FS, fractional shortening; IVSTD, interventricular septal thickness at end diastole; IVSTS, interventricular septal thickness at end systole; LV, left ventricular; LVID, left internal dimension at diastole; LVIDs, left internal dimension at systole; LVM, left ventricular mass; LVPWTD, left ventricular posterior wall thickness at diastole; LVPWTS, left ventricular posterior wall thickness at systole; RR, relative risk.

a

P<0.05.